SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-20-000669
Filing Date
2020-01-29
Accepted
2020-01-29 16:13:22
Documents
1
Period of Report
2020-01-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 7730
  Complete submission text file 0001562180-20-000669.txt   9053
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 550 HILLS DRIVE, THIRD FLOOR BEDMINSTER NJ 07921
Business Address
Firuta Paul E (Reporting) CIK: 0001602727 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33095 | Film No.: 20558301